Hepatitis c, chronic Trials in Toronto, Canada
Conditions / Hepatitis c, chronic / Toronto, Canada
Hepatitis c, chronic has been the subject of sustained clinical investigation across multiple research sites.
30 total trials for this combination
Showing top 10 of 30 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01457768 | A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response | COMPLETED | — |
| NCT01358864 | Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3) | COMPLETED | PHASE3 |
| NCT01457755 | Gilead Sustained Virologic Response (SVR) Registry | COMPLETED | — |
| NCT00516321 | Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease | COMPLETED | PHASE3 |
| NCT01459913 | Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype | TERMINATED | PHASE3 |
| NCT00394277 | A Study of Induction Dosing With PEGASYS (Peginterferon Alfa-2a [40KD]) Plus Copegus in Treatment-Naive Patients With Chronic Hepatitis C | COMPLETED | PHASE4 |
| NCT00087646 | REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination Therapy | COMPLETED | PHASE4 |
| NCT01001754 | Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus Infection | UNKNOWN | PHASE2 |
| NCT00529568 | Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease | COMPLETED | PHASE3 |
| NCT01168856 | An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens | TERMINATED | — |